Pranoot Tanpaiboon

1.8k total citations
55 papers, 820 citations indexed

About

Pranoot Tanpaiboon is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Pranoot Tanpaiboon has authored 55 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 17 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in Pranoot Tanpaiboon's work include Lysosomal Storage Disorders Research (21 papers), Metabolism and Genetic Disorders (13 papers) and Glycogen Storage Diseases and Myoclonus (8 papers). Pranoot Tanpaiboon is often cited by papers focused on Lysosomal Storage Disorders Research (21 papers), Metabolism and Genetic Disorders (13 papers) and Glycogen Storage Diseases and Myoclonus (8 papers). Pranoot Tanpaiboon collaborates with scholars based in United States, Thailand and United Kingdom. Pranoot Tanpaiboon's co-authors include Piranit Nik Kantaputra, Denise Salazar, Rubén Bonilla Guerrero, Barbara K. Burton, Jerry Vockley, Nicola Longo, Stephanie Grünewald, John G. Phillips, Elaine Murphy and Amarilis Sanchez‐Valle and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and JAMA Pediatrics.

In The Last Decade

Pranoot Tanpaiboon

54 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pranoot Tanpaiboon United States 18 329 285 229 186 183 55 820
Francesca Menni Italy 17 208 0.6× 271 1.0× 156 0.7× 162 0.9× 173 0.9× 46 1.0k
Shuan-Pei Lin Taiwan 19 371 1.1× 239 0.8× 122 0.5× 158 0.8× 206 1.1× 39 793
Simona Fecarotta Italy 17 299 0.9× 207 0.7× 75 0.3× 127 0.7× 144 0.8× 41 775
Elena Procopio Italy 16 165 0.5× 407 1.4× 164 0.7× 88 0.5× 53 0.3× 47 670
Néji Tebib Tunisia 14 164 0.5× 164 0.6× 89 0.4× 112 0.6× 89 0.5× 66 537
David Ketteridge Australia 15 739 2.2× 239 0.8× 124 0.5× 60 0.3× 263 1.4× 31 1.1k
Anna Elsa Maria Allegri Italy 18 108 0.3× 285 1.0× 42 0.2× 161 0.9× 63 0.3× 43 830
Jayesh Sheth India 18 318 1.0× 277 1.0× 31 0.1× 243 1.3× 132 0.7× 111 938
Norberto Guelbert Argentina 16 514 1.6× 148 0.5× 48 0.2× 58 0.3× 232 1.3× 39 651
Yavuz Renda Türkiye 16 159 0.5× 215 0.8× 59 0.3× 55 0.3× 60 0.3× 45 786

Countries citing papers authored by Pranoot Tanpaiboon

Since Specialization
Citations

This map shows the geographic impact of Pranoot Tanpaiboon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pranoot Tanpaiboon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pranoot Tanpaiboon more than expected).

Fields of papers citing papers by Pranoot Tanpaiboon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pranoot Tanpaiboon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pranoot Tanpaiboon. The network helps show where Pranoot Tanpaiboon may publish in the future.

Co-authorship network of co-authors of Pranoot Tanpaiboon

This figure shows the co-authorship network connecting the top 25 collaborators of Pranoot Tanpaiboon. A scholar is included among the top collaborators of Pranoot Tanpaiboon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pranoot Tanpaiboon. Pranoot Tanpaiboon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Rajesh, et al.. (2024). Biotinidase biochemical and molecular analyses: Experience at a large reference laboratory. Pediatrics International. 66(1). e15726–e15726. 5 indexed citations
2.
Lau, Heather, David Viskochil, Pranoot Tanpaiboon, et al.. (2022). Long-term efficacy and safety of vestronidase alfa enzyme replacement therapy in pediatric subjects < 5 years with mucopolysaccharidosis VII. Molecular Genetics and Metabolism. 136(1). 28–37. 4 indexed citations
3.
Duong, Tina, Priya S. Kishnani, Kristina An Haack, et al.. (2022). Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant Cohort. Journal of Neuromuscular Diseases. 9(6). 713–730. 3 indexed citations
5.
Tim‐Aroon, Thipwimol, Pranoot Tanpaiboon, Nithiwat Vatanavicharn, et al.. (2021). Infantile onset Sandhoff disease: clinical manifestation and a novel common mutation in Thai patients. BMC Pediatrics. 21(1). 22–22. 6 indexed citations
6.
Byrne, Barry J., Steven D. Colan, Priya S. Kishnani, et al.. (2021). Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohort. Cardiology in the Young. 32(3). 364–373. 6 indexed citations
7.
8.
Mohan, Parvathi, et al.. (2020). A patient with atypical presentation of chronic hepatosteatosis harboring a novel variant in the CPT1A gene. European Journal of Medical Genetics. 64(1). 104034–104034. 1 indexed citations
10.
Synofzik, Matthis, Katherine L. Helbig, Florian Harmuth, et al.. (2018). De novo ITPR1 variants are a recurrent cause of early-onset ataxia, acting via loss of channel function. European Journal of Human Genetics. 26(11). 1623–1634. 30 indexed citations
11.
Vockley, Jerry, Barbara K. Burton, Gerard T. Berry, et al.. (2017). UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24 weeks of treatment. Molecular Genetics and Metabolism. 120(4). 370–377. 58 indexed citations
12.
Tanpaiboon, Pranoot. (2016). Lysosomal storage disorders. 4(4). 217–229.
13.
Kantaputra, Piranit Nik, Hülya Kayserili, Yeliz Güven, et al.. (2014). Clinical manifestations of 17 patients affected with mucopolysaccharidosis type VI and eight novel ARSB mutations. American Journal of Medical Genetics Part A. 164(6). 1443–1453. 19 indexed citations
14.
Kantaputra, Piranit Nik, et al.. (2013). Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI. Journal of Inherited Metabolic Disease. 37(2). 263–268. 31 indexed citations
15.
Cairns, James R. Ketudat, Siriporn Keeratichamroen, Pranoot Tanpaiboon, et al.. (2012). Decreasing Activity and Altered Protein Processing of Human Iduronate-2-sulfatase Mutations Demonstrated by Expression in COS7 Cells. Biochemical Genetics. 50(11-12). 990–997. 10 indexed citations
16.
Tanpaiboon, Pranoot, Jennifer L. Sloan, Dorothea McAreavey, et al.. (2012). Noncompaction of the Ventricular Myocardium and Hydrops Fetalis in Cobalamin C Disease. JIMD Reports. 10. 33–38. 17 indexed citations
17.
Tanpaiboon, Pranoot, et al.. (2010). Phenotypic analysis of Arg227 mutations of TP63 with emphasis on dental phenotype and micturition difficulties in EEC syndrome. American Journal of Medical Genetics Part A. 155(1). 228–232. 14 indexed citations
18.
Tanpaiboon, Pranoot, et al.. (2009). Expanding the phenotypic spectrum of acro‐cardio‐facial syndrome (ACFS): Exclusion of P63 mutation. American Journal of Medical Genetics Part A. 149A(8). 1749–1753. 3 indexed citations
19.
Kantaputra, Piranit Nik, et al.. (2004). Microcephalic osteodysplastic primordial dwarfism with severe microdontia and skin anomalies: Confirmation of a new syndrome. American Journal of Medical Genetics Part A. 130A(2). 181–190. 17 indexed citations
20.
Kantaputra, Piranit Nik & Pranoot Tanpaiboon. (2004). A newly recognized syndrome involving limbs, pelvis, and genital organs or a variant of Al‐Awadi/Raas‐Rothschild syndrome?. American Journal of Medical Genetics Part A. 132A(1). 63–67. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026